Genetic risk factors for chronic obstructive pulmonary disease

Clinics in Chest Medicine

Volumn 21, Issue 4, 2000, Pages 633-643

  Sandford, Andrew J ^a   Paré, Peter D ^b,c  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; MICROSOME ENZYME; NICOTINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D BINDING PROTEIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HYPERCAPNIA; HYPOXIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; XENOBIOTIC METABOLISM;

EID: 0034525046     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70173-8     Document Type: Article

References (93)

1. 2
2. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis
3. Molecular genetics of chronic obstructive pulmonary disease
4. Protease inhibitors in chronic obstructive pulmonary disease
5. Smoking and lung function
6. 1-antichymotrypsin mutations in patients with obstructive pulmonary disease
7. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease
8. Genetic and social influences on starting to smoke: A study of Dutch adolescent twins and their parents
9. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles: Relevance for inflammatory bowel disease
10. 1-antitrypsin deficiency of adults with pulmonary symptoms
11. Relevance of the tumor necrosis factor α (TNF-α-308 promoter polymorphism in TNF-α gene regulation
12. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects
13. 1-Antitrypsin gene polymorphism related to respiratory system disease
14. The emphysematous and bronchial types of chronic airways obstruction: A clinicopathological study of patients in London and Chicago
15. Tracheobronchial clearance in twins
16. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer
17. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung
18. Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industries
19. Segregation analysis of two lung function indices in a random sample of young families: The Humboldt Family Study
20. A common familial component in lung cancer and chronic obstructive pulmonary disease
21. Hereditary aspects of decreased hypoxic response
22. The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking
23. Relationship between genotype and function of the human CYP1A1 gene
24. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis
25. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis
26. 1-antitrypsin deficiency: A longitudinal lung function study
27. Family resemblance for normal pulmonary function
28. Abnormal distribution of cystic fibrosis ΔF508 allele in adults with chronic bronchial hypersecretion
29. 1-antitrypsin deficiency (PiMZ) on lung function
30. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
31. Sweat chloride and ΔF508 mutation in chronic bronchitis or bronchiectasis
32. Segregation analysis of pulmonary function among families in the Framingham Study
33. 1-antitrypsin deficiency
34. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer
35. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
36. Genetic models for the natural history of smoking: Evidence for a genetic influence on smoking persistence
37. Normal values for hypoxic and hypercapnic ventilatory drives in man
38. Possible protective effect against chronic obstructive airways disease by the GC 2 allele
39. 1-Antitrypsin heterozygotes (Pi type MZ). A longitudinal study of the risk of development of chronic air flow limitation
40. Tumor necrosis factor-α gene polymorphism in chronic bronchitis
41. Genetic and environmental influences on pulmonary function in adult twins
42. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease
43. 1-antitrypsin deficiency
44. 1-antitrypsin gene are associated with chronic obstructive airways disease
45. Familial factors related to lung function in children aged 6-10 years: Results from the PAARC epidemiologic study
46. Familial aggregation of abnormal ventilatory control and pulmonary function in chronic obstructive pulmonary disease
47. Control of breathing in young twins
48. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg
49. Genetic-environmental interactions in chronic airways obstruction
50. Inter-individual and interspecies variation in hepatic microsomal epoxide hydrolase activity: Studies with cisstilbene oxide, carbamazepine 10, 11-epoxide and naphthalene
51. 1-antitrypsin deficiency
52. 1-antitrypsin phenotype groups in a community population
53. Evidence suggesting the role of specific genetic factors in cigarette smoking
54. Genetic variation of CYP2A6, smoking, and risk of cancer
55. Risk factors for obstructive lung disease
56. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: The Virginia Twin Study of Adolescent Behavioral Development
57. 1-Antitrypsin deficiency alleles and the Taq-I-G - >A allele in cystic fibrosis lung disease
58. 1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence
59. 1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors
60. Hypoventilation in obstructive lung disease. The role of familial factors
61. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism
62. D2 dopamine receptor gene and cigarette smoking: A reward gene?
63. 1-antitrypsin deficiency
64. Long-term lung clearance in humans studied with Teflon particles labeled with chromium-51
65. Nicotine metabolism defect reduces smoking
66. CFTR gene variant IVS8-5T in disseminated bronchiectasis
67. 2-macroglobulin deficiency
68. Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease: Application in the identification of a cystic fibrosis patient with atypical clinical course
69. 1-antichymotrypsin allele associated with familial obstructive lung disease
70. 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease
71. Assessment of genetic and nongenetic influences on pulmonary function: A twin study
72. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins
73. Disseminated bronchiectasis and cystic fibrosis gene mutations
74. A genetic association for cigarette smoking behavior
75. 1-Antitrypsin genotypes and the acute-phase response to open heart surgery
76. 1-antitrypsin gene and chronic obstructive pulmonary disease
77. Genetic risk factors for chronic obstructive pulmonary disease
78. 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease
79. Vitamin D-binding protein variants and the risk of COPD
80. 1-antitrypsin deficiency with special reference to non-index cases
81. Severe, early-onset COPD: Linkage analysis of chromosomes 5q and 12q
82. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population
83. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
84. Familial aggregation of chronic respiratory disease: Use of National Health Interview Survey data for specific hypothesis testing
85. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
86. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons
87. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease
88. Household aggregation of pulmonary function and chronic bronchitis
89. Longitudinal lung function study in heterozygous PiMZ phenotype subjects
90. 1-antitrypsin deficiency (Pi MZ)
91. 1antitrypsin deficiency
92. Vitamin D-binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes